Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Jun;54(6):2744-5.
doi: 10.1128/AAC.00241-10. Epub 2010 Mar 22.

Raltegravir penetration in seminal plasma of healthy volunteers

Clinical Trial

Raltegravir penetration in seminal plasma of healthy volunteers

Andrea Calcagno et al. Antimicrob Agents Chemother. 2010 Jun.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Scatter-dot representation of plasma (filled markers) and seminal (empty markers) concentrations (ng/ml) over time. A single patient's concentrations are represented with the same symbol.

Similar articles

Cited by

References

    1. Barau, C., C. Delaugerre, J. Braun, N. de Castro, V. Furlan, I. Charreau, L. Gérard, C. Lascoux-Combe, J. M. Molina, and A. M. Taburet. 2010. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. Antimicrob. Agents Chemother. 54:937-939. - PMC - PubMed
    1. Chan, D. J. 2005. Pathophysiology of HIV-1 in semen: current evidence for compartmentalisation and penetration by antiretroviral drugs. Curr. HIV Res. 3:207-222. - PubMed
    1. D'Avolio, A., L. Baietto, M. Siccardi, M. Sciandra, M. Simiele, V. Oddone, S. Bonora, and G. Di Perri. 2008. An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients. Ther. Drug Monit. 30:662-669. - PubMed
    1. Jones, A. E., J. A. Talameh, K. B. Patterson, N. L. Rezk, H. A. Prince, and A. D. M. Kashuba. 2009. First-dose and steady-state pharmacokinetics of raltegravir in the genital tract of HIV negative women, abstr. O-06. Abstr. 10th Int. Workshop Clin. Pharmacol. HIV Ther., Amsterdam, Netherlands, 15 April to 1 May 2009.
    1. Kalichman, S. C., G. Di Berto, and L. Eaton. 2008. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex. Transm. Dis. 35:55-60. - PubMed